BIOLASE Showcases Advanced YSGG Laser Solutions for Predictable Oral Health at AAP 2025
/
/
BIOLASE Showcases Advanced YSGG Laser Solutions for Predictable Oral Health at AAP 2025

BIOLASE Showcases Advanced YSGG Laser Solutions for Predictable Oral Health at AAP 2025

TORONTO, October 15, 2025 – BIOLASE, a leading global dental laser technology company, will showcase its breakthroughs in periodontal care at the American Academy of Periodontology (AAP) 2025 Corporate Forum, October 15-18, in Toronto.

On Wednesday, October 15, at 2:05 p.m. in Room 709, Philip Kang, D.D., will present a keynote speech titled, “Redefining Periodontitis Treatment: A Novel YSGG Laser Protocol for Predictable Pocket Reduction.”

The presentation will introduce an innovative Er,Cr:YSGG laser-assisted surgical protocol designed to standardize periodontal pocket reduction procedures and improve predictability, efficiency, and patient comfort.

Attendees will learn how this novel approach achieves:

Predictable pocket reduction

Effective bacterial decontamination

Precise bone reshaping with minimal trauma

Leveraging YSGG laser technology, this approach provides sustained, long-term periodontal health, making laser therapy a key tool in modern periodontology.

BIOLASE invites attendees to experience the company’s most advanced full-tissue laser system, the Waterlase iPlus Premier Edition™, at booth 1004. Attendees who try the device will receive a complimentary BIOLASE travel mug.

The Waterlase iPlus is supported by a landmark blinded study designed by The McGuire Institute™ and published in the Journal of Periodontology, which demonstrated:

Reduced bleeding, swelling, and post-operative discomfort

Faster procedures with comparable results to open flap surgery

Superior patient-reported outcomes aligned with the American Dental Association (AAP) Best Evidence Consensus Recommendations

“BIOLASE is committed to advancing the science and precision of dental lasers to help patients worldwide receive better care,” said Dr. Kwang Bum Park, CEO of BIOLASE.

Our presence at the AAP 2025 conference underscores our commitment to innovation, empowering clinicians, and improving outcomes.”

WhatsApp